Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
ACS Medicinal Chemistry Letters|October 20, 2022
Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat ConjugatesYosuke Ota, Yukihiro Itoh, Takashi Kurohara, et al.Journal of Medicinal Chemistry|December 25, 2015
Identification of SNAIL1 Peptide-Based Irreversible Lysine-Specific Demethylase 1-Selective InactivatorsYukihiro Itoh, Keisuke Aihara, Paolo Mellini, et al.Journal of Medicinal Chemistry|October 17, 2023
Discovery of Selective Histone Deacetylase 1 and 2 Inhibitors: Screening of a Focused Library Constructed by Click Chemistry, Kinetic Binding Analysis, and Biological EvaluationYukihiro Itoh, Peng Zhan, Toshifumi Tojo, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2026
Definitive IMRT alone with reduced prophylactic nodal irradiation for Early-Stage Oropharyngeal Cancer: JCOG1208Satoaki Nakamura, Takeshi Kodaira, Ryunosuke Machida, et al.Radiation Oncology (London, England)|July 28, 2022
Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)Masahiro Inada, Yasumasa Nishimura, Satoshi Ishikura, et al.International Journal of Clinical Oncology|March 30, 2020
A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015)Yasumasa Nishimura, Satoshi Ishikura, Taro Shibata, et al.International Journal of Clinical Oncology|April 17, 2024
A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancerKatsumasa Nakamura, Keiji Nihei, Yoshihiro Saito, et al.Oncotarget|March 10, 2016
Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapySimon J Dovedi, Amy L Adlard, Yosuke Ota, et al.Pageof 6